Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DB26FWQTZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,847
Award facts
- Contract value 100% obligated
- $13,846.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Vyndamax 61 mg capsules in unit-dose packaging (30-count). The award, with an ultimate completion date of November 17, 2025, is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order operates under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Vyndamax (tafamidis) is a specialty medication used to treat transthyretin cardiac amyloidosis. Under the DLA Troop Support Medical IDC framework, AmerisourceBergen Drug Corp supplies a broad portfolio of pharmaceutical products and medical commodities across multiple therapeutic domains to support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems. The company's demonstrated capability to fulfill federal medical supply requirements through open competition, coupled with its extensive experience managing delivery orders with firm fixed pricing across various transaction values, reinforces its role as a key pharmaceutical provider within the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB26FWQTZ?
SPE2DB26FWQTZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FWQTZ worth?
The government has obligated $13,847 on SPE2DB26FWQTZ.
Is contract SPE2DB26FWQTZ an order under another contract?
Yes. SPE2DB26FWQTZ is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB26FWQTZ competed?
The extent of competition for SPE2DB26FWQTZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award